Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?

Radujkovic, A.; Guglielmi, C.; Bergantini, S.; Iacobelli, S.; Biezen, A. van; Milojkovic, D.; ... ; Chronic Malignancies Working Party (2015)

Article / Letter to editor

• Chronic myeloid leukemia
• Allogeneic stem cell transplantation
• Donor lymphocyte infusions
• Relapse
• Graft-versus-host disease
• Graft-versus-leukemia

• All authors: Radujkovic, A.; Guglielmi, C.; Bergantini, S.; Iacobelli, S.; Biezen, A. van; Milojkovic, D.; Gratwohl, A.; Schattenberg, A.V.M.B.; Verdonck, L.F.; Niederwieser, D.W.; Witte, T. de; Kroger, N.; Olavarria, E.; Chronic Malignancies Working Party
• Date: 2015-07-31
• Journal: Biology of Blood and Marrow Transplantation
• Volume: 21
• Issue: 7
• Pages: 1230 - 1236
• DOI: doi:10.1016/j.bbmt.2015.03.012